“Because utilization of robotic hysterectomy for benign indications in Michigan is so much higher than the national average, the generalizability our findings might be limited,” she said. “Also, our cost data were based on estimates from the literature and were not linked to cases in our database, which would have been ideal.”
The meeting was jointly sponsored by the American College of Surgeons.
Dr. Swenson reported having no financial disclosures.